Kamada (KMDA) Non Operating Income (2012 - 2026)

Kamada (KMDA) posted quarterly Non Operating Income of $1.6 million for Q1 2026, up 32.15% year-on-year from $1.2 million in Q1 2025, and up 232.04% on a QoQ basis from -$1.2 million in Q4 2025.

Kamada (KMDA) Non Operating Income (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Non Operating Income for 15 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Non Operating Income rose 32.15% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (up 44.14% YoY) and the FY2025 annual result came in at $2.8 million, down 58.82% from the prior year.
  • Non Operating Income advanced to $1.6 million in Q1 2026 per KMDA's latest filing, from -$1.2 million in the prior quarter.
  • Over the last five years, Non Operating Income for KMDA reached as high as $2.6 million in Q4 2024 and fell as low as -$2.2 million in Q4 2023.
  • A 5-year average of $828444.4 and a median of $1.2 million in 2025 frame the typical range for Non Operating Income.
  • Annual changes were most pronounced in 2022 — Non Operating Income jumped 729.41% — and 2023, when it sank 309.7%.
  • Year by year, Non Operating Income stood at $1.1 million in 2022, then plunged by 309.7% to -$2.2 million in 2023, then jumped by 216.5% to $2.6 million in 2024, then plunged by 145.17% to -$1.2 million in 2025, then soared by 232.04% to $1.6 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $1.6 million, -$1.2 million, and $1.2 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.56 Mn
Dec 31, 2025 -1.18 Mn
Mar 31, 2025 1.18 Mn
Dec 31, 2024 2.62 Mn
Sep 30, 2024 1.35 Mn
Dec 31, 2023 -2.25 Mn
Sep 30, 2023 1.07 Mn
Dec 31, 2022 1.07 Mn
Mar 31, 2022 2.03 Mn
Dec 31, 2021 1.36 Mn
Jun 30, 2021 537,000.00
Mar 31, 2021 -323,000.00
Dec 31, 2020 739,000.00
Jun 30, 2020 1.42 Mn
Mar 31, 2020 -774,000.00
Dec 31, 2019 -33,000.00
Jun 30, 2019 -195.00
Mar 31, 2019 156,000.00
Dec 31, 2018 -417,000.00
Jun 30, 2018 -129.00